A Multi-Center Phase 1 Study of the Safety and Tolerability of Dimebon in Alzheimer's Disease Patients on Memantine (Cohort 1) and Memantine Plus Donepezil (Cohort 2).
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2015
At a glance
- Drugs Donepezil; Latrepirdine; Memantine
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Medivation
- 10 Apr 2010 Status changed from active, no longer recruiting to completed as per results reported at 62nd Annual Meeting of the American Academy of Neurology.
- 10 Apr 2010 Results presented at 62nd Annual Meeting of the American Academy of Neurology.
- 16 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History